| |
| |
|
| Insider
Information: |
Anderson Bonnie H |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
75,036 |
|
|
Indirect Shares
|
156,523 |
|
|
| Direct
Value |
$1,519,563 |
|
|
|
Indirect Value
|
$2,869,892 |
|
|
| Total
Shares |
231,559 |
|
|
| Total
Value |
$4,389,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -33.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Director |
2023-06-02 |
41,377 |
2023-06-02 |
134,800 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2019-07-29 |
23,630 |
2020-07-17 |
21,723 |
Premium* |
|
|
Bruker Corp |
BRKR |
|
2024-01-05 |
10,029 |
2020-09-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
162 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-23 |
4 |
AS |
$32.04 |
$105,106 |
D/D |
(3,280) |
272,207 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-21 |
4 |
AS |
$32.09 |
$110,614 |
D/D |
(3,447) |
272,207 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2021-01-12 |
4 |
OE |
$5.61 |
$114,186 |
D/D |
20,354 |
224,110 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-12-29 |
4 |
OE |
$2.68 |
$116,919 |
D/D |
31,313 |
203,756 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-12-10 |
4 |
OE |
$2.68 |
$120,200 |
D/D |
35,000 |
117,738 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-09-02 |
4 |
D |
$52.97 |
$121,195 |
D/D |
(2,288) |
64,544 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-01-10 |
4 |
AS |
$15.52 |
$125,248 |
D/D |
(8,000) |
76,541 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-03-02 |
4 |
D |
$27.84 |
$125,865 |
D/D |
(4,521) |
69,021 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-09-17 |
4 |
AS |
$50.18 |
$130,478 |
I/I |
(2,600) |
217,478 |
0 |
% |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-16 |
4/A |
AS |
$42.90 |
$130,659 |
I/I |
(3,000) |
21,723 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-17 |
4 |
AS |
$42.90 |
$130,659 |
I/I |
(3,000) |
21,723 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-05-12 |
4 |
AS |
$35.00 |
$140,000 |
I/I |
(4,000) |
30,723 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-02-11 |
4 |
AS |
$18.17 |
$145,364 |
D/D |
(8,000) |
76,541 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-03-11 |
4 |
AS |
$19.97 |
$159,746 |
D/D |
(8,000) |
102,592 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-20 |
4 |
OE |
$4.00 |
$171,287 |
D/D |
20,349 |
292,556 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2018-08-02 |
4 |
AS |
$11.50 |
$171,925 |
D/D |
(14,950) |
52,541 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-08-10 |
4 |
OE |
$8.86 |
$177,200 |
D/D |
20,000 |
242,207 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-09-10 |
4 |
OE |
$8.86 |
$177,200 |
D/D |
20,000 |
240,231 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-11-10 |
4 |
OE |
$8.86 |
$177,200 |
D/D |
20,000 |
240,231 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-05-10 |
4 |
AS |
$22.77 |
$183,948 |
D/D |
(8,000) |
95,292 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-01-17 |
4 |
OE |
$5.61 |
$190,740 |
D/D |
34,000 |
96,961 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-03-15 |
4 |
OE |
$5.61 |
$190,740 |
D/D |
34,000 |
87,967 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-04-14 |
4 |
OE |
$5.61 |
$190,740 |
D/D |
34,000 |
76,681 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-10-10 |
4 |
AS |
$24.50 |
$196,005 |
D/D |
(8,000) |
103,726 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2019-09-10 |
4 |
AS |
$23.27 |
$196,114 |
D/D |
(8,000) |
104,426 |
0 |
- |
|
162 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
